Eurofins Diatherix utilizes Proprietary TEM-PCR™ and other molecular technologies to deliver fast, actionable results when they are needed the most.

Proprietary TEM-PCR™ improves the success of an accurate clinical diagnosis with the following benefits:

• Optimizes target amplification conditions that improve both sensitivity and specificity of difficult-to-identify pathogens

• Improves the identification of infectious organisms in patients who are already on empirical antibiotic regimens

• Identifies both viruses and bacteria that have synergistic roles in more complex infections

 

Accurate detection and co-detection of problematic bacteria and viruses can result in significant improvements during the patient treatment process. Having this precise knowledge can allow the clinician to determine the right course of action and preclude inappropriate antibiotic therapy.

• Delivers one-day results

• Identifies bacteria regardless of recent antibiotic use

• Offers simplicity of single-sample collection

• Identifies difficult-to-culture pathogens

• Yields a high level of sensitivity and specificity

• Click for RESPIRATORY TEST MENU 
• Click link for Genital Health, SSTI/Wound, Urinary Tract and Gastrointestinal Test Menu GGUW TEST MENU

Eurofins Diatherix Research and Development

The Eurofins Diatherix Research and Development Team strives to be dynamic and nimble by developing solutions to improve patient outcomes through application of Eurofins Diatherix TEM-PCR™ and related technologies. The R&D Team drives the development of these new tests by listening to feedback from clinicians, identifying unmet needs, and delivering to medical care providers solutions with which they can better serve their patients. All tests are monitored on a recurrent basis to ensure content is current and inclusive of new and emerging strains.